Product
CMV Cytotoxic T-Lymphocytes
1 clinical trial
1 indication
Indication
Congenital Cytomegalovirus InfectionClinical trial
A Phase II Open-Label Randomized Study of Anti-Viral Antibiotic Therapy With and Without Familial (Maternal) Cytomegalovirus (CMV) Cytotoxic T Lymphocytes (CTLs) in Neonates With Moderate/Severe Maternal Acquired CMV InfectionStatus: Recruiting, Estimated PCD: 2027-10-31